OMNICELL, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OMNICELL, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	696	716	787	897	892	1,132	1,296	1,147	1,112	1,185
Cost of revenue	379	394	415	460	479	577	707	650	641	681
Gross profit	317	319	372	437	413	555	589	497	471	503
Research and development	57.8	66	64.8	68.6	70.2	75.7	105	97.1	90.4	88.7
Selling, general and administrative	238	241	263	290	308	389	486	435	380	410
Operating expenses	296	307	328	359	378	465	591	532	471	498
Operating income	21.4	11.1	44.4	78.4	35.5	89.5	-2.32	-34.9	0.34	5.16
Interest expense	5.3	6.3	7.5	3.6
Other non-operating income	-8.43	-6.63	-8.78	-4.42	-6.18	-23.5	-0.13	14.8	25.3	6.17
Pre-tax income	13	4.51	35.6	73.9	29.3	66	-2.45	-20.1	25.6	11.3
Income tax	3.22	-26	-2.11	12.6	-2.85	-11.8	-8.1	0.26	13.1	9.27
Net income	9.76	30.5	37.7	61.3	32.2	77.8	5.65	-20.4	12.5	2.05
EBITDA	79.8	62.7	95.7	132	96.6	162	84.6	52.5	82.6	84
EPS, basic	0.27	0.81	0.96	1.48	0.76	1.79	0.13	-0.45	0.27	0.04
EPS, diluted	0.26	0.79	0.93	1.43	0.74	1.62	0.12	-0.45	0.27	0.04
Shares, basic (weighted)	36.2	37.5	39.2	41.5	42.6	43.5	44.4	45.2	46	46
Shares, diluted (weighted)	36.9	38.7	40.6	42.9	43.7	47.9	45.9	45.2	46.3	46.4

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	54.5	32.4	67.2	127	486	349	330	468	369	197
Receivables	150	190	196	218	190	241	299	252	256	217
Inventory	69.3	96.1	101	108	96.3	120	148	110	88.7	101
Other current assets	12.7	13.3	12.1	15.2	41	48.3	77.4	71.5	75.3	132
Total current assets	315	352	397	483	829	781	882	928	815	680
Property, plant and equipment	42	42.6	51.5	54.2	59.1	71.1	94	109	113	120
Lease right-of-use assets			0	56.1	55.1	48.5	38.1	25	25.6	24.4
Goodwill	328	338	336	337	499	739	734	736	735	738
Intangible assets	190	168	144	125	168	278	243	211	188	170
Other non-current assets	35.1	49.3	74.6	103	119	128	105	90.5	79.3	70.2
Total assets	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121	1,975
Accounts payable	27.1	48.3	38	46.4	40.3	71.5	63.4	45	51.8	44
Accrued liabilities	31.2	35.7	43	55.6	80.3	133	173	149	168	204
Deferred revenue	87.5	78.8	81.8	90.9	100	112	119	122	141	172
Short-term debt	8.41	15.2	0
Total current liabilities	181	205	205	237	276	876	428	368	596	477
Long-term debt	246	195	135	50
Lease liabilities			0	50.7	48.9	39.9	39.4	33.9	31.1	24.8
Other non-current liabilities	8.21	9.83	9.56	11.7	19.2	7.84	6.72	6.32	7.22	9.97
Total liabilities	503	462	402	396	857	996	1,081	1,038	878	743
Total debt	254	210	140	50
Paid-in capital	526	586	678	781	920	1,025	1,047	1,122	1,168	1,224
Retained earnings	100	160	197	259	291	369	391	370	383	385
Treasury stock	-185	-185	-185	-185	-238	-238	-290	-290	-290	-368
Other comprehensive income	-9.52	-6.11	-10.9	-9.45	-5.52	-8.41	-17.1	-13.4	-17.2	-8.85
Shareholders' equity	459	554	680	845	968	1,147	1,130	1,189	1,243	1,232
Total equity	459	554	680	845	968	1,147	1,130	1,189	1,243	1,232
Total liabilities and equity	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121	1,975
Shares outstanding	36.6	38.4	40.3	42.1	42.8	44.2	44.7	45.5	46.4	45

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	9.76	30.5	37.7	61.3	32.2	77.8	5.65	-20.4	12.5	2.05
Depreciation and amortization	58.4	51.5	51.4	53.6	61.1	73	86.9	87.3	82.2	78.8
Stock-based compensation	19.5	21.9	28.9	34	44.7	53.2	68.2	55.3	39.3	44.5
Deferred income tax	-4.87	-31	-6.12	-1.2	-7.1	-3.95	-34.3	-10.6	-14.6	-0.51
Change in receivables	9.93	-40.6	-6.19	-21.5	36.8	-41	-60.4
Change in inventory	-3.36	-26.8	-6.76	-8.12	12.4	-25.7	-30.1	38	15.6	-11.2
Change in payables	-4.96	19.7	-9.15	7.89	-6.3	29.1	-7.75	-17.5	7.21	-9.28
Cash from operations	49.9	24.8	104	145	186	232	77.8	181	188	127
Capital expenditures	-13.4	-15.3	-23.7	-15.9	-22.8	-29	-47.5	-41.5	-36.5	-40.4
Acquisitions	-312	-4.45	0	0	-225	-354	-3.39	0	0
Cash from investing	-341	-35	-54.4	-61.7	-280	-412	-58.7	-55	-52.8	-60.4
Debt issued		59	0	0
Debt repaid	-34.5	-103	-77	-90	-200	0	0
Stock issued	0	13.9	39.6	37.8	0	0
Share buybacks	0	0	0	0	-53	0	-52.2	0	0	-77.6
Cash from financing	264	-9.88	-13.6	-23.5	456	47.4	-21	23.4	-236	-218
Exchange rate effect	-0.06	-2.03	-1.23	0.15	0.44	-0.97	-0.94	-1.35	-1.72	3.8
Net change in cash	-27.7	-22.1	34.8	60	363	-134	-2.79	148	-102	-148
Free cash flow	36.5	9.49	80.3	129	163	203	30.2	140	151	86.9
Interest paid	5.34	6.55	7.49	3.58	0.52	1.92	1.44	1.44	1.62	2.2
Income taxes paid	11.1	7.78	3.49	7.76	10.3	-1.73	19	20.2	11.3	18.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $33.66 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	44.8%	Gross profit / revenue.
Operating margin	4.6%	Operating income / revenue.
EBITDA margin	10.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.9%	Pre-tax income / revenue.
Net margin	3.1%	Net income / revenue.
FCF margin	11.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	14.6%	Cash from operations / revenue.
Effective tax rate	36.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.0%	Net income / average total assets.
Return on invested capital (ROIC)	3.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	7.1%	Research and development expense / revenue.
SG&A / revenue	33.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	3.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	6.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	6.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-5.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1,431.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	-32.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	1.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-2.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-83.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-28.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-42.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-85.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-30.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-44.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-32.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	17.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-42.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	42.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-11.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-0.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-6.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.64x	Current assets / current liabilities.
Quick ratio	1.16x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.65x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	35.4%	Total liabilities / total assets.
Working capital	$287.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	44.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$393.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.62x	Revenue / average total assets.
Fixed asset turnover	10.2x	Revenue / average property, plant and equipment.
Inventory turnover	7.12x	Cost of revenue / average inventory.
Days inventory	51 days	365 x average inventory / cost of revenue.
Receivables turnover	5.49x	Revenue / average receivables.
Days sales outstanding	66 days	365 x average receivables / revenue.
Days payables	26 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	91 days	Days inventory + days sales outstanding - days payables.
FCF conversion	364.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	21.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.93	Revenue / diluted weighted shares.
FCF per share	$3.08	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.92	Cash from operations / diluted weighted shares.
Book value per share	$28.32	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$8.63	Tangible book value / shares outstanding.
Cash per share	$6.41	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.54B	Share price x shares outstanding.
Enterprise value	$1.24B	Market cap + total debt - cash - short-term investments.
P/E	39.3x	Market cap / net income. Only when net income is positive.
P/S	1.23x	Market cap / revenue.
P/B	1.19x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.90x	Market cap / tangible book value, when positive.
P/FCF	10.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.46x	Market cap / cash from operations, when positive.
EV/Sales	1.00x	Enterprise value / revenue.
EV/EBIT	21.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.24x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.72x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.3%	Free cash flow / market cap.
Earnings yield	2.5%	Net income / market cap (the inverse of P/E).

What was OMNICELL, INC.'s revenue in fiscal 2025?

OMNICELL, INC. reported revenue of $1.18B for fiscal 2025, 6.5% higher than the year before.

Was OMNICELL, INC. profitable in fiscal 2025?

Yes. Net income was $2.1M, a net margin of 0.2%.

How much free cash flow did OMNICELL, INC. generate in fiscal 2025?

Cash from operations of $127.3M minus capital expenditures of $40.4M left free cash flow of $86.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to OMNICELL, INC.